Evidence map›Paper›PMID 28395173›Full record

ArticleRedox biology2017

Particular phosphorylation of PI3K/Akt on Thr308 via PDK-1 and PTEN mediates melatonin's neuroprotective activity after focal cerebral ischemia in mice.

Ulkan Kilic, Ahmet Burak Caglayan, Mustafa Caglar Beker, Mehmet Yalcin Gunal, Berrak Caglayan, Esra Yalcin, Taha Kelestemur, Reyhan Zeynep Gundogdu, Burak Yulug, Bayram Yılmaz and 2 more

Open access · goldAbstract read
In one paragraph

Article in Redox biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it, 128 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Pinealectomy-Induced Neuroinflammation Varies with Age in Rats.International journal of molecular sciences · 2025
    Article
  11. Literature review of advances and challenges inTranslational lung cancer research · 2025
    Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ulkan KilicRegenerative and Restorative Medical Research Center, Istanbul Medipol University, Istanbul, Turkey; Dept. of Medical Biology, Istanbul Medipol University, Turkey.
Ahmet Burak CaglayanRegenerative and Restorative Medical Research Center, Istanbul Medipol University, Istanbul, Turkey; Dept. of Physiology, Istanbul Medipol University, Turkey.
Mustafa Caglar BekerRegenerative and Restorative Medical Research Center, Istanbul Medipol University, Istanbul, Turkey; Dept. of Physiology, Istanbul Medipol University, Turkey.
Mehmet Yalcin GunalRegenerative and Restorative Medical Research Center, Istanbul Medipol University, Istanbul, Turkey; Dept. of Physiology, Istanbul Medipol University, Turkey.
Berrak CaglayanRegenerative and Restorative Medical Research Center, Istanbul Medipol University, Istanbul, Turkey; Dept. of Physiology, Istanbul Medipol University, Turkey.
Esra YalcinRegenerative and Restorative Medical Research Center, Istanbul Medipol University, Istanbul, Turkey; Dept. of Physiology, Istanbul Medipol University, Turkey.
Taha KelestemurRegenerative and Restorative Medical Research Center, Istanbul Medipol University, Istanbul, Turkey; Dept. of Physiology, Istanbul Medipol University, Turkey.
Reyhan Zeynep GundogduRegenerative and Restorative Medical Research Center, Istanbul Medipol University, Istanbul, Turkey; Dept. of Physiology, Istanbul Medipol University, Turkey.
Burak YulugRegenerative and Restorative Medical Research Center, Istanbul Medipol University, Istanbul, Turkey; Dept. of Neurology, Istanbul Medipol University, Turkey.
Bayram YılmazDept. of Physiology, Yeditepe University, Istanbul, Turkey.
Bilal Ersen KermanRegenerative and Restorative Medical Research Center, Istanbul Medipol University, Istanbul, Turkey; Dept. of Histology and Embryology, Istanbul Medipol University, Turkey.
Ertugrul KilicRegenerative and Restorative Medical Research Center, Istanbul Medipol University, Istanbul, Turkey; Dept. of Physiology, Istanbul Medipol University, Turkey. Electronic address: kilic44@yahoo.com.
Istanbul Medipol University · TRYeditepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apart from its potent antioxidant property, recent studies have revealed that melatonin promotes PI3K/Akt phosphorylation following focal cerebral ischemia (FCI) in mice. However, it is not clear (i) whether increased PI3K/Akt phosphorylation is a concomitant event or it directly contributes to melatonin's neuroprotective effect, and (ii) how melatonin regulates PI3K/Akt signaling pathway after FCI. In this study, we showed that Akt was intensively phosphorylated at the Thr308 activation loop as compared with Ser473 by melatonin after FCI. Melatonin treatment reduced infarct volume, which was reversed by PI3K/Akt inhibition. However, PI3K/Akt inhibition did not inhibit melatonin's positive effect on brain swelling and IgG extravasation. Additionally, phosphorylation of mTOR, PTEN, AMPKα, PDK1 and RSK1 were increased, while phosphorylation of 4E-BP1, GSK-3α/β, S6 ribosomal protein were decreased in melatonin treated animals. In addition, melatonin decreased apoptosis through reduced p53 phosphorylation by the PI3K/Akt pathway. In conclusion, we demonstrated the activation profiles of PI3K/Akt signaling pathway components in the pathophysiological aspect of ischemic stroke and melatonin's neuroprotective activity. Our data suggest that Akt phosphorylation, preferably at the Thr308 site of the activation loop via PDK1 and PTEN, mediates melatonin's neuroprotective activity and increased Akt phosphorylation leads to reduced apoptosis.

Indexed as

AnimalsAntioxidantsBrain IschemiaDisease Models, AnimalGene Expression RegulationImmunoglobulin GMelatoninMicePhosphatidylinositol 3-KinasesPhosphorylationProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePyruvate Dehydrogenase Acetyl-Transferring KinaseSignal TransductionThreonineAntioxidantsImmunoglobulin GMelatoninPDK1 protein, humanPdk1 protein, mousePhosphatidylinositol 3-KinasesProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktPTEN PhosphohydrolasePTEN protein, humanPyruvate Dehydrogenase Acetyl-Transferring KinaseThreonineBrain injuryMelatoninPI3K/Akt signaling pathwayPI3K inhibition

Identifiers

PMID28395173
PMCPMC5388917
OpenAlexW2604907374

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.